Medication for Appetite Stimulation in Elderly Patients
Primary Recommendation
Mirtazapine 7.5 mg at bedtime is the first-line pharmacological agent for appetite stimulation in elderly patients, particularly when concurrent depression may be present, with dosing up to 30 mg at bedtime and requiring 4-8 weeks for full therapeutic assessment. 1
Clinical Decision Algorithm
Step 1: Assess for Dementia and Depression Status
If the patient has dementia WITHOUT depression:
- Do NOT use any appetite stimulants - the evidence shows no consistent benefit and potentially harmful side effects outweigh uncertain benefits for appetite and body weight 2, 1, 3
- This recommendation has 89% consensus agreement from Clinical Nutrition guidelines 2
- Focus exclusively on non-pharmacological interventions instead 3
If the patient has depression OR no dementia:
- Proceed to pharmacological options below 1
Step 2: First-Line Pharmacological Treatment
Mirtazapine is the preferred agent because:
- It addresses both appetite loss and potential underlying depression simultaneously 1
- Start at 7.5 mg at bedtime for elderly patients 1
- Maximum dose is 30 mg at bedtime 1
- Bedtime dosing is ideal due to sedating properties 1
- Expected outcomes: mean weight gain of 1.9 kg at 3 months and 2.1 kg at 6 months, with approximately 80% experiencing some weight gain 1
- Full therapeutic trial requires 4-8 weeks to assess efficacy 1
Important FDA-labeled side effects to monitor: 4
- Somnolence (54% vs 18% placebo)
- Increased appetite (17% vs 2% placebo) - this is the desired effect
- Weight gain (12% vs 2% placebo) - this is the desired effect
- Dry mouth (25% vs 15% placebo)
- Constipation (13% vs 7% placebo)
- Dizziness (7% vs 3% placebo)
Step 3: Alternative Agents if Mirtazapine Fails or is Contraindicated
Megestrol acetate 400-800 mg daily: 1, 5
- Approximately 1 in 4 patients will have increased appetite 1
- Approximately 1 in 12 patients will gain weight 1
- Critical safety concerns: thromboembolic events, edema, vaginal spotting, adrenal suppression, and higher rates of deaths compared to placebo 3
- May attenuate benefits of resistance training, causing smaller gains or deterioration in muscle strength and functional performance 1
- Use with extreme caution in elderly patients 1
Dexamethasone 2-8 mg/day: 1, 5
- Faster onset of action, making it suitable for patients with shorter life expectancy 5
- Significant side effects with prolonged use including hyperglycemia, muscle wasting, and immunosuppression 5
Step 4: Monitoring and Reassessment
Regular monitoring is essential: 1
- Reassess benefit versus harm at regular intervals 1, 5
- After 9 months of mirtazapine treatment, consider dosage reduction to reassess need for continued medication 1
- Discontinue mirtazapine over 10-14 days to limit withdrawal symptoms 1
What NOT to Use
Cannabinoids are NOT recommended: 3
- Three small placebo-controlled trials in dementia patients found no significant effect on body weight, BMI, or energy intake 3
- Multiple guidelines conclude evidence is insufficient to support routine use 3
- Cannabinoid administration in elderly patients may induce delirium 3
Flavor enhancing additives should NOT be routinely used to promote food intake 2
Critical Caveats
The one absolute contraindication: Never use appetite stimulants in patients with dementia who do not have concurrent depression - this has strong consensus (89% agreement) from Clinical Nutrition guidelines 2, 1, 3
Before starting any medication: 1
- Investigate treatable causes of poor appetite (oral/dental problems, medication side effects, cholinesterase inhibitors) 3
- Review all current medications that may contribute to poor appetite 1
- Consider temporarily discontinuing non-essential medications 1
Non-pharmacological approaches should be implemented concurrently: 1, 5, 3
- Encourage shared meals with family or other patients to improve intake 1
- Offer smaller, more frequent meals with favorite foods 1
- Provide energy-dense options to maximize nutritional intake 1
- Consider fortified foods and oral nutritional supplements when dietary intake falls to 50-75% of usual intake 1, 3
- Place patients at dining tables rather than isolated in rooms 5
- Provide emotional support, supervision, and verbal prompting during mealtimes 5